[HTML][HTML] Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine

M Rosenkranz, K Fürle, J Hibbert, A Ulmer, A Ali… - npj Vaccines, 2023 - nature.com
Radical control of malaria likely requires a vaccine that targets both the asymptomatic liver
stages and the disease-causing blood stages of the human malaria parasite Plasmodium …

Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine.

M Rosenkranz, K Fürle, J Hibbert, A Ulmer, A Ali… - 2023 - cabidigitallibrary.org
Radical control of malaria likely requires a vaccine that targets both the asymptomatic liver
stages and the disease-causing blood stages of the human malaria parasite Plasmodium …

Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 “SumayaVac-1” malaria vaccine in a phase I clinical trial

M Rosenkranz, K Fürle, J Hibbert, A Ulmer, A Ali… - sumaya-biotech.com
Radical control of malaria likely requires a vaccine that targets both the asymptomatic liver
stages and the disease-causing blood stages of the human malaria parasite Plasmodium …

Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine

M Rosenkranz, K Fürle, J Hibbert, A Ulmer, A Ali… - NPJ …, 2023 - search.proquest.com
Radical control of malaria likely requires a vaccine that targets both the asymptomatic liver
stages and the disease-causing blood stages of the human malaria parasite Plasmodium …

Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine.

M Rosenkranz, K Fürle, J Hibbert, A Ulmer… - NPJ …, 2023 - search.ebscohost.com
Radical control of malaria likely requires a vaccine that targets both the asymptomatic liver
stages and the disease-causing blood stages of the human malaria parasite Plasmodium …

Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine.

M Rosenkranz, K Fürle, J Hibbert, A Ulmer, A Ali… - NPJ …, 2023 - europepmc.org
Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1
SumayaVac-1 malaria vaccine. - Abstract - Europe PMC Sign in | Create an account …

[HTML][HTML] Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine

M Rosenkranz, K Fürle, J Hibbert, A Ulmer, A Ali… - NPJ …, 2023 - ncbi.nlm.nih.gov
Radical control of malaria likely requires a vaccine that targets both the asymptomatic liver
stages and the disease-causing blood stages of the human malaria parasite Plasmodium …

Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine

M Rosenkranz, K Fürle, J Hibbert, A Ulmer… - NPJ …, 2023 - pubmed.ncbi.nlm.nih.gov
Radical control of malaria likely requires a vaccine that targets both the asymptomatic liver
stages and the disease-causing blood stages of the human malaria parasite Plasmodium …

[引用][C] Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine

M Rosenkranz, K Fürle, J Hibbert, A Ulmer, A Ali… - europepmc.org
Recent years have witnessed an increase in malaria incidence and mortality to an estimated
247 million clinical cases and 619,000 deaths as of 2021 1. Apparently, the currently …